Literature DB >> 8350402

Reactivation of transcription from a vaccinia virus early promoter late in infection.

J Garcés1, K Masternak, B Kunz, R Wittek.   

Abstract

We have studied the kinetics of RNA synthesis from the vaccinia virus 7,500-molecular-weight gene (7.5K gene) which is regulated by early and late promoters arranged in tandem. Unexpectedly, after a first burst of RNA synthesis early in infection, transcription was reactivated late in infection. Reactivation was not dependent on the location of the promoter in the genome or on the presence of the upstream late regulatory sequences. The mRNA synthesized from the reactivated promoter in the late phase had the same 5' and 3' ends as the molecules transcribed in the early phase. Interestingly, these molecules were efficiently translated despite the absence of the poly(A) leader characteristic of late mRNAs. Reactivation appears to be dependent on virus assembly since it is prevented by rifampin, a specific inhibitor of morphogenesis. Finally, analysis of various other early genes showed that reactivation is not unique to the 7.5K early promoter.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8350402      PMCID: PMC237940     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  The complete DNA sequence of vaccinia virus.

Authors:  S J Goebel; G P Johnson; M E Perkus; S W Davis; J P Winslow; E Paoletti
Journal:  Virology       Date:  1990-11       Impact factor: 3.616

2.  Identification, sequence, and expression of the gene encoding the second-largest subunit of the vaccinia virus DNA-dependent RNA polymerase.

Authors:  B Y Amegadzie; M H Holmes; N B Cole; E V Jones; P L Earl; B Moss
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

Review 3.  Regulation of vaccinia virus transcription.

Authors:  B Moss
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.

Authors:  J G Keck; C J Baldick; B Moss
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  Structure of vaccinia virus late promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

6.  Identification of factors specific for transcription of the late class of vaccinia virus genes.

Authors:  C F Wright; B Moss
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

7.  Identification of rpo30, a vaccinia virus RNA polymerase gene with structural similarity to a eucaryotic transcription elongation factor.

Authors:  B Y Ahn; P D Gershon; E V Jones; B Moss
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

8.  Mutational analysis of a vaccinia virus intermediate promoter in vivo and in vitro.

Authors:  P Hirschmann; J C Vos; H G Stunnenberg
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

9.  Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.

Authors:  P L Earl; A W Hügin; B Moss
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

10.  Derepression of a novel class of vaccinia virus genes upon DNA replication.

Authors:  J C Vos; H G Stunnenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  9 in total

1.  Phenotypic analysis of a temperature sensitive mutant in the large subunit of the vaccinia virus mRNA capping enzyme.

Authors:  Amber N Shatzer; Sayuri E M Kato; Richard C Condit
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

2.  cis- and trans-acting elements involved in reactivation of vaccinia virus early transcription.

Authors:  K Masternak; R Wittek
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

3.  De novo synthesis of the early transcription factor 70-kilodalton subunit is required for morphogenesis of vaccinia virions.

Authors:  X Hu; L J Carroll; E J Wolffe; B Moss
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

Review 4.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.

Authors:  Magdalini Moutaftsi; David C Tscharke; Kerrie Vaughan; David M Koelle; Lawrence Stern; Mauricio Calvo-Calle; Francis Ennis; Masanori Terajima; Gerd Sutter; Shane Crotty; Ingo Drexler; Genoveffa Franchini; Jon W Yewdell; Steven R Head; Janice Blum; Bjoern Peters; Alex Sette
Journal:  Future Microbiol       Date:  2010-02       Impact factor: 3.165

5.  Targeting of a multicomponent transcription apparatus into assembling vaccinia virus particles requires RAP94, an RNA polymerase-associated protein.

Authors:  Y Zhang; B Y Ahn; B Moss
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

6.  Repression of the A8L gene, encoding the early transcription factor 82-kilodalton subunit, inhibits morphogenesis of vaccinia virions.

Authors:  X Hu; E J Wolffe; A S Weisberg; L J Carroll; B Moss
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Myxoma virus encodes an alpha2,3-sialyltransferase that enhances virulence.

Authors:  R J Jackson; D F Hall; P J Kerr
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels.

Authors:  Naif Khalaf Alharbi; Fahad Aljamaan; Haya A Aljami; Mohammed W Alenazi; Hind Albalawi; Abdulrahman Almasoud; Fatima J Alharthi; Esam I Azhar; Tlili Barhoumi; Mohammad Bosaeed; Sarah C Gilbert; Anwar M Hashem
Journal:  Vaccines (Basel)       Date:  2022-08-17

9.  A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions.

Authors:  Marica Grossegesse; Joerg Doellinger; Berit Haldemann; Lars Schaade; Andreas Nitsche
Journal:  Viruses       Date:  2017-10-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.